Health Secretary Wes Streeting expressed gratitude for the opportunity to meet with former Little Mix member Jesy Nelson, commending her bravery in sharing her personal story. Nelson met with Streeting to advocate for the implementation of newborn screening for spinal muscular atrophy (SMA), the disease afflicting her twin babies, which hinders their ability to walk.
The Mirror is campaigning for the inclusion of a simple £5 SMA check in the NHS newborn heel prick test to enable early detection and treatment, preventing irreversible nerve damage. Streeting acknowledged Nelson’s compelling argument for enhanced screening, revealing plans for a significant study on newborn SMA screening and a trial within the NHS to screen hundreds of thousands of babies.
Streeting emphasized the progress in available treatments for SMA, noting the increasing number of children thriving with the condition. The meeting with Nelson, alongside the charity SMA UK, highlighted the urgent need for timely diagnoses to prevent severe consequences. A portion of the meeting will be featured on ITV’s This Morning.
Novartis, a pharmaceutical company, estimated that 33 UK infants annually suffer from delayed diagnoses of SMA, leading to disability. Zolgensma, a gene therapy provided by Novartis, has been introduced in the NHS as a potential cure if administered promptly after birth to prevent muscle neuron loss.
Rob Hastings, Novartis UK’s chief medical officer, expressed sympathy for Nelson’s family and advocated for expanding newborn SMA screening in the UK to align with European standards. Late diagnosis of severe SMA often results in children requiring extensive support, highlighting the urgency for early intervention.
Nelson, a first-time mother, emphasized the emotional impact of her twins’ diagnosis and the importance of timely treatment to prevent irreversible muscle damage. Her candid revelations on the challenges of late diagnosis have spurred discussions on improving screening procedures and access to genomic medicine.
By sharing her personal journey, Nelson has brought attention to the critical need for early detection and treatment of SMA in infants. Her advocacy has inspired efforts to enhance newborn screening protocols, aiming to provide all children with the best chance for a healthy and active future.